Pharma Pulse 11/13/24: FDA's Exemption for DSCSA Compliance, Pharmacists Combat Flu Misinformation and Expand Vaccine Access & more

Understanding the FDA's Exemption for DSCSA Compliance

In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.

Pharmacists Combat Flu Misinformation and Expand Vaccine Access

In an interview, Kristi Veis, PharmD, RPh, vice president of pharmacy at Hi-School Pharmacy, discusses misinformation, immunization clinics, and her own experiences as an immunizer.

European Stocks Drop Most in Three Months as Trump Worries Mount

European stocks dropped the most in over three months, amid worries that President-elect Donald Trump’s policies will stoke inflation and that his plans to increase tariffs could hit growth in the region.

48% of Americans Have Been Unable to Fill a Needed Prescription Due to Cost

Navitus Health Solutions revealing that 48% reported that the price of medication had affected their ability to get a medicine they needed at least once. The survey looked at consumer attitudes around drug pricing and awareness around issues impacting pricing. Notably, 88% believe prescription drug pricing should be a priority for the next administration following the election.

Phesi on LinkedIn

💬 Our Founder and President, Gen Li, PhD, MBA, sat down with Pharmaceutical Executive to discuss the growing issue of non-active and non-enrolling investigator sites in #ClinicalDevelopment.

Selecting the best investigator sites has always been challenging, but the clinical development industry is approaching a crisis point. 🔍

In the Q&A, Gen emphasizes that sponsors must adopt a data-driven approach to #ClinicalTrial design to identify the most experienced investigators, select investigator sites with precision, and ultimately increase the success rate of trials. 📈

Read the full piece here: https://lnkd.in/eyNMAXyd

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs